Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Alvaro Ruibal

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Cytosol

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
26
Tejerina, Armando
15
Schneider, José
15
Arias, José Ignacio
13
del Río, Mari Carmen
13
Núñez, Matilde Isabel
12
Vizoso, Francisco
9
Lapeña, G
8
Rodríguez, Jesús
7
Nuñez, MI
6
Núñez, MJ
6
Piqueras, V
6
Sánchez-Salmón, Aida
5
Resino, C
4
Pardo, C
4
García Díez, Susana

Sign-in to see all Coauthors

Publications

TOP 3
Ruibal Alvaro; Abdulkader Ihab; Gude Francisco; León L
[The maximum standardized uptake value (18)F-FDG PET is independent of the immunohistochemical expression of platelet derived endothelial growth factor in patients with non-small cell lung cancer.]
Ruibal A; Abdulkader I; Gude F; Pombo M; León L; Barandela J; Sánchez-Salmón A
[The immunohistochemical expression of cyclooxygenase 2 is inversely associated with (18)F-FDG-PET SUV values in non-small-cell lung cancers. Initial results]
Ruibal Alvaro; Maldonado Antonio; Sánchez Salmón Aída; González-Alenda Javier; Barandela Julio
[18FDG-PET in patients with in situ breast carcinomas. A cause of false negative results]

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Alvaro Ruibal (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ruibal Alvaro; Abdulkader Ihab; Gude Francisco; León L
[The maximum standardized uptake value (18)F-FDG PET is independent of the immunohistochemical expression of platelet derived endothelial growth factor in patients with non-small cell lung cancer.]
Medicina clínica 2009;132(16):645-6.
2009: Ruibal A; Abdulkader I; Gude F; Pombo M; León L; Barandela J; Sánchez-Salmón A
[The immunohistochemical expression of cyclooxygenase 2 is inversely associated with (18)F-FDG-PET SUV values in non-small-cell lung cancers. Initial results]
Revista española de medicina nuclear 2009;28(1):11-4.
2008: Ruibal Alvaro; Maldonado Antonio; Sánchez Salmón Aída; González-Alenda Javier; Barandela Julio
[18FDG-PET in patients with in situ breast carcinomas. A cause of false negative results]
Medicina clínica 2008;130(9):332-3.
2007: Ruibal A; Sánchez Salmón A; Garrido M; Bogdan Ciobotaru A; Arias J I
[Preoperative CA15.3 serum levels and cellular proliferation in patients having infiltrating ductal carcinomas of the breast]
Revista española de medicina nuclear 2007;26(6):367-71.
2007: Sánchez-Salmón A; Barandela J; Garrido M; Ciobotaru A B; Albo C; Ruibal A
[Evolution in 18F-FDG-PET of a case of Hodgkin disease, nodular sclerosis variety, after treatment and autotrasplant]
Revista española de medicina nuclear 2007;26(3):165-8.
2006: Sánchez-Salmón Aida; Ruibal Alvaro
[Current value of positron emission tomography for prostate cancer follow-up]
Archivos españoles de urología 2006;59(10):1021-9.
2006: Fernández L P; Milne R L; Barroso E; Cuadros M; Arias J I; Ruibal A; Benítez J; Ribas G
Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study.
International journal of cancer. Journal international du cancer 2006;119(2):467-71.
2006: Ruibal A; Garrido Pumar M; Arias J I
[Preoperative serum CA15.3 and CEA levels and clinical-biological parameters in breast tumors]
Revista española de medicina nuclear 2006;25(3):180-3.
2006: Ruibal A; Garrido-Pumar M; Arias J I
[Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers]
Revista española de medicina nuclear 2006;25(1):15-9.
2005: Ruibal Alvaro; del Río Mari Carmen; Arias José Ignacio
[CD44v6 expression in er-negative and PgR-negative infiltrating ductal breast carcinomas]
Medicina clínica 2005;125(12):475-6.
2005: Peña Carlos; Jaquet Michel; Salgado Julio; Pubul Virginia; Ruibal Alvaro; Vázquez Begoña
[Asymmetric pulmonary perfusion causing unilateral pulmonary edema as a complication of acute myocardial infarction]
Revista española de cardiología 2005;58(7):875-7.
2005: Sánchez Salmón A; Argibay S; Arias J I; Ruibal A
[Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast]
Revista española de medicina nuclear 2005;24(3):185-90.
2005: Ruibal A; Nuñez Cambre I; Sánchez Salmón A; Nuñez M I; Rodríguez J
[CA125 cytosolic levels in lung adenocarcinomas. New biological aspects]
Revista española de medicina nuclear 2005;24(1):27-31.
2004: Argibay S; Díaz J; Núñez I; Sánchez A; Barandela J; Pubul V; Gómez J; Rey R; Ruibal A
[Hepatic abscess demonstrated by 67Ga-citrate scintigraphy within a diagnosis of fever of unknown origin]
Revista española de medicina nuclear 2004;23(6):417-20.
2004: Rodríguez-López Raquel; Osorio Ana; Ribas Gloria; Pollán Marina; Sánchez-Pulido Luis; de la Hoya Miguel; Ruibal Alvaro; Zamora Pilar; Arias Jose Ignacio; Salazar Raquel; Vega Ana; Martínez Jose Ignacio; Esteban-Cardeñosa Eva; Alonso Carmen; Letón Rocío; Urioste Azcorra Miguel; Miner Cristina; Armengod M Eugenia; Carracedo Angel; González-Sarmiento Rogelio; Caldés Trinidad; Díez Orland; Benítez Javier
The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations.
International journal of cancer. Journal international du cancer 2004;110(6):845-9.
2004: Ruibal Alvaro; Arias José Ignacio
[Axillary lymph node involvement in hormone-independent breast carcinomas]
Medicina clínica 2004;123(2):50-2.
2004: Arias Jose A; Pardo Carlos; Olmos Antonio; Cuadrado Maria L; Ruibal Alvaro
Dental diseases and radionuclide imaging of the jaws.
Nuclear medicine communications 2004;25(3):305-10.
2004: Ruibal Alvaro; Núñez M I; Rodríguez J
[CD44s expression in squamous cell lung carcinomas]
Medicina clínica 2004;122(6):237.
2004: Ruibal A; Núñez Cambre I; Núñez M I; Rodríguez J
[Cytosolic CA125 in lung squamous cell carcinomas]
Revista española de medicina nuclear 2004;23(1):46-8.
2003: Resino M C; Sánchez Hermosa C; Lapeña G; Pardo C; Ruibal A; Medina C; San Román J M
[Preoperative lymphoscintigraphy to identify the sentinel lymph node in breast cancer]
Revista española de medicina nuclear 2003;22(6):410-7.
2003: Ruibal A; Nuñez M I; Rodríguez J; Jiménez L; del Rio M C; Zapatero J
Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung.
The International journal of biological markers 2003;18(3):188-94.
2003: Ruibal A; Nuñez M I; del Rio M C; Salmón A Sánchez; Rodriguez J
Cytosolic levels of free beta subunit of human chorionic gonadotrophin hormone in non-small cell lung cancers: correlation with other clinical and biological parameters.
The International journal of biological markers 2003;18(2):156-8.
2003: Ruibal A; Arias J I
[Biological features characteristic of the mucinous carcinoma of the breast]
Revista española de medicina nuclear 2003;22(2):122-4.
2003: Ruibal A; Núñez M I; del Río M C; Pardo C; Rodríguez J
[CD44s Cell surface expression in 55 lung adenocarcinomas. Negative correlation with tumor size and CA125 cytosolic levels]
Revista española de medicina nuclear 2003;22(2):82-6.
2003: Ruibal Alvaro; Núñez Matilde Isabel; Río María del Carmen; García Díez Susana; Rodríguez Jesús; Alvarez de Linera José Feliciano
[Cytosolic cathepsin D levels in squamous carcinomas of the lung]
Medicina clínica 2003;120(3):81-4.
2003: Ruibal A; Núñez M I; Pardo C; Rodríguez J
[Study of epidermal growth factor receptor concentration (EGFR) in lung adenocarcinomas. Association with high erbB2 oncogenic protein levels]
Revista española de medicina nuclear 2003;22(1):40-2.
2002: Ruibal Alvaro; Arias José I; Aldecoa Belén
[Clinical and biological differences between infiltrating ductal carcinomas of the breast in women over 70 years-old and those aged 60-70]
Medicina clínica 2002;119(20):761-4.
2002: Ruibal A; Arias J I
[Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors]
Revista española de medicina nuclear 2002;21(6):437-8.
2002: Ruibal A; Núñez M I; Del Río M C; Lapeña G; Rodríguez J
[CYFRA 21.1 cytosol levels in lung adenocarcinomas. Correlation with other clinico-biological parameters]
Revista española de medicina nuclear 2002;21(5):333-7.
2002: Ruibal Alvaro; Núñez Matilde Isabel; Del Río Mari Carmen; Rodríguez Jesús; Alvarez De Linera José Feliciano
[Usefulness of cytosolic tissue-type plasminogen activator levels in lung adenocarcinomas]
Medicina clínica 2002;119(1):1-3.
2002: Ruibal A; Núñez M I; del Río M C; García Díez S; Rodríguez J; Alvarez De Linera J A
[Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters]
Revista española de medicina nuclear 2002;21(2):109-14.
2002: Alvarez-Millán J J; Bocos C; Ferrín V; Lucas A R; Ruibal A; Schneider J
PAI-1 promoter polymorphism modulates uPA-PAI complex accumulation by breast cancer cells.
Oncology 2002;62(3):286-90.
2001: Ruibal A; Arias J; Del Río M C; Resino C; Tejerina A
[Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations]
Revista española de medicina nuclear 2001;20(7):525-9.
2001: Resino C; Arias J I; Del Río M C; Sánchez Hermosa C; Ruibal A
[Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein]
Revista española de medicina nuclear 2001;20(6):503-5.
2001: Ruibal A; Arias J I; Resino C; Lapeña G; Schneider J; Tejerina A
[Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation]
Revista española de medicina nuclear 2001;20(5):365-8.
2001: Ruibal A; Arias J; Lapeña G; García Díez S; Tejerina A
[Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters]
Revista española de medicina nuclear 2001;20(4):332-3.
2001: Ruibal A; Núñez M J; Piqueras V; Rabadán F; Lapeña G; Schneider J; Tejerina A
[Human gonadotrophic hormone (HCG) in benign breast cyst fluid. Association between type I and type II biological activities]
Revista española de medicina nuclear 2001;20(2):156-8.
2001: Ruibal A; Schneider J; Núñez M J; Piqueras V; Martínez Arribas F; Esquivel E; García Díez S; Tejerina A
[Carcinoembryonic antigen levels (CEA) in 67 breast secretions caused by mammary duct ectasia]
Revista española de medicina nuclear 2001;20(1):19-22.
2001: Ruibal A; Arias J I; Del Río M C; Lapeña G; Schneider J; Tejerina A
Histological grade in breast cancer: association with clinical and biological features in a series of 229 patients.
The International journal of biological markers 2001;16(1):56-61.
2000: Ruibal A; Piqueras V; Núñez M J; Resino C; Rabadán F; Schneider J; Tejerina A
[Electrophoretic patterns of lactate dehydrogenase isoenzymes in fluid from 261 benign breast cysts]
Medicina clínica 2000;115(20):761-3.
2000: Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
Anticancer research 2000;20(6B):4373-7.
2000: Ruibal A; Arias J; del Río M C; San Román J M; Lapeña G; Pardo C; Tejerina A
[Clinico-biological impact of pS2 positivity in estrogen receptor negative-infiltrating ductal carcinomas of the breast]
Revista española de medicina nuclear 2000;19(6):428-33.
2000: Ruibal A; Schneider J; del Río M C; Arias J; Núñez M I; Tejerina A
[Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases]
Revista española de medicina nuclear 2000;19(5):350-5.
2000: Piqueras V; Núñez M J; Rabadán F; Schneider J; Tejerina A; Ruibal A
[Carcinoembryonic antigen concentrations in breast cystic fluids increase in type II fluids regardless of whether there are multiple cysts or one cyst. A study of 152 cases]
Revista española de medicina nuclear 2000;19(4):313-4.
2000: Ruibal A; Arias J; del Río M C; Lapeña G; Resino C; Tejerina A
[Clinicobiological study of membrane hyaluronic acid index /CD44v5 (AHm/CD44v5) in patients with infiltrating ductal breast carcinoma]
Revista española de medicina nuclear 2000;19(4):311-2.
2000: Ruibal A; Arias J I; Carmen del Río M; San Román J M; Lapeña G; Schneider J; Tejerina A
[The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast]
Medicina clínica 2000;115(6):201-7.
2000: Schneider J; Lucas R; Sánchez J; Tejerina A; Ruibal A
Cellular accumulation of uPA-PAI-1 [correction of UPA-PAI-1] and uPA-PAI-2 [correction of UPA-PAI-2] complexes in early (pT1) breast cancer: a new link in the uPA-UPAr-PAI chain.
In vivo (Athens, Greece) 2000;14(4):507-11.
2000: Ruibal A; del Río M C; Arias J; Schneider J; Tejerina A
[Clinical and biological differences between tetraploid and hypertetraploid infiltrating ductal carcinomas of the breast. Preliminary study]
Revista española de medicina nuclear 2000;19(3):247-8.
2000: Ruibal A; Schneider J; Arias J; del Río M C; Núnez M J; Tejerina A
[Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women]
Revista española de medicina nuclear 2000;19(3):244-6.
2000: Ruibal A; Arias J; Del Rio M C; Schneider J; Tejerina A
Study of the expression on the CD44v5 adhesion molecule in invasive lobular carcinomas of the breast. Association between negativity and cellular S-phase fraction >7%.
The International journal of biological markers 2000;15(2):195-6.
1999: Schneider J; Pollán M; Ruibal A; Jiménez E; Lucas A R; Núñez M I; Sánchez J; Tejerina A
Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1999;20(6):319-30.
1999: Ruibal A; Piqueras V; Núñez M J; del Río M C; Arias J; Schneider J; Tejerina A
[Study of G2M cell fraction by flow cytometry in 200 infiltrating ductal breast carcinomas. Correlation with receptor positivity of the epidermal growth factor, cathepsin D and histological grade 3]
Revista española de medicina nuclear 1999;18(4):312-4.
1999: Ruibal A; Schneider J; del Rio C; Arias J; Núñez M J; Piqueras V; Tejerina A
pS2 negativity in postmenopausal women with ER+PgR+ infiltrating ductal breast carcinoma is associated with reduced hormone dependence and increased proliferation and aneuploidy of the tumors.
The International journal of biological markers 1999;14(3):186-8.
1999: Ruibal A; Núñez M I; Arias J; Tejerina A
[Clinical and biological differences between infiltrating mucinous and lobular breast carcinomas without axillary lymph node involvement]
Medicina clínica 1999;112(8):315.
1999: Ruibal A; Núñez M I; Schneider J; del Río M f; Delgado S; Rabadán F; Tejerina A
[Absence of correlation between the concentrations of carcinoembryonic antigen (CEA) and the tumor growth factor beta 2 (TGFB2) in the two main types of breast macrocysts]
Revista española de medicina nuclear 1999;18(2):88-93.
1999: Ruibal A; Núñez M I; del Río M f; Arias J; Martínez M I; Rabadán J; Tejerina A
[Clinical-biological differences between invasive ductal carcinomas and breast lobular carcinomas. Preliminary results]
Revista española de medicina nuclear 1999;18(2):84-7.
1998: Ruibal A; Nuñez M I; Schneider J; Del Rio M C; Rabadan F; Tejerina A
Transforming growth factor beta 2 (TGF beta 2) and dehydroepiandrosterone sulphate (DHEAs) levels in breast macrocyst fluids. Different behaviour according to cyst type.
The International journal of biological markers 1998;13(3):173-5.
1998: Ruibal A; Nuñez M I; Arias J; Folgueras V; Garcia Miralles M T; Tejerina A
Clinical and biological differences between diploid and hyperdiploid infiltrating ductal carcinomas of the breast.
The International journal of biological markers 1998;13(1):42-4.
1998: Ruibal A; Núñez M; Tejerina A
[Hyaluronic acid concentrations in cell membranes are inversely proportional to histological grade and ploidy in infiltrating ductal carcinoma of the breast]
Revista española de medicina nuclear 1998;17(4):310-1.
1996: Nuñez M I; Arias J I; Del Rio M C; Martinez M I; Alba A; Allende M T; Ruibal A
Cell surface CD44v5 levels correlate with progesterone receptors and a tumor size > 2 cm in infiltrating ductal carcinomas of the breast.
The International journal of biological markers 1996;11(4):220-2.
1996: Ruibal A; Fernández Llana B; Alba A; Nuñez M I; Martinez I; Allende M T
CYFRA 21.1 cytosolic levels in breast diseases. Correlation with other clinical and biological parameters.
The International journal of biological markers 1996;11(2):90-2.
1995: García Muñiz J L; Alvarez A; Fernández Llana B; Fernández Raigoso P; Allende M T; Ruibal A
Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters.
The International journal of biological markers 1995;10(2):119-21.
1994: Ruibal A; Alvarez A; Fernández Llana B; Fernández Fernández M; Roiz M C; Allende M T
Cytosolic tissue-type plasminogen activator (t-PA) levels in breast tumors and hormone dependence. Role of pS2.
The International journal of biological markers 1994;9(4):251-3.
1993: Fernández Llana B; Fernández Fernández M; Fernández Raigoso P; Alvarez A; Allende M T; Ruibal A
Placental serum alkaline phosphatase, defined by monoclonal antibody C2, in non-malignant diseases and in non-germinal tumors.
The International journal of biological markers 1993;8(4):246-8.
1993: Fernandez Fernandez M; Fernandez Llana B; Fernandez Raigoso P; Roiz M C; Allende M T; Ruibal A
CAM26 cytosol levels seem to be correlated with pS2 expression in breast cancer.
The International journal of biological markers 1993;8(1):25-6.
1992: Suarez B; Vizoso F; Allende M T; Fernández Fernández M; Fdez Llana B; Roiz M C; Ruibal A
Active androgens in breast cyst fluids.
The International journal of biological markers 1992;7(4):263-4.
1992: Vizoso F; Allende M T; García-Muñiz J L; Alexandre E; Fueyo A; Ruibal A
Serum prolactin levels in women with gross cystic breast disease.
The International journal of biological markers 1992;7(4):225-9.
1992: Suárez B; Fernández Llana B; Allende M T; Ruibal A
[Cytosol concentrations of CAM29 in breast carcinoma. Effect of the pS2]
Revista clínica española 1992;191(5):284.
1992: Allende M T; Fernández Fernández M; Fernández Llana B; Ruibal A
[Cytosolic oncogenic neu protein determined with enzyme immunoassay: approximation to a marker of clinical application]
Revista clínica española 1992;191(6):334-5.
1992: Suarez B; González C; Allende M T; Fernández Fernández M; Fernández Llana B; Roiz M C; Vizoso F; Ruibal A
CAM26 and CAM29 cytosol levels in breast tumors classified according to estrogen receptor status. First results.
The International journal of biological markers 1992;7(2):126-8.
1992: Vizoso F; Allende M T; Fernández Fernández M; Suarez B; Fernández Llana B; Roiz M C; Ruibal A
Total lactate dehydrogenase and tumor necrosis factor alpha levels in cyst fluid of women with gross cystic breast disease.
The International journal of biological markers 1992;7(2):123-5.
1991: Allende M T; Fernández Fernández M; Fernández Llana B; Suarez B; Vizoso F; Ruibal A
Serum BCM-IMx levels in 376 patients with non-malignant diseases.
The International journal of biological markers 1991;6(4):253-5.
1991: Allende M T; Vizoso F; Mosquera E; Fernández Fernández M; Fernández Llana B; Ruibal A
Different immunoreactivity between cyst fluid and serum prolactin in women with cystic breast disease.
The International journal of biological markers 1991;6(3):199-200.
1991: Roiz M C; Allende M T; Vivanco J; Ruibal A
[Simultaneous assay of SLX and CEA does not increase the clinical usefulness of the latter in patients with colorectal carcinoma]
Revista clínica española 1991;188(5):266-7.
1991: Allende M T; Hernández J; Bianco A; Del Rosal M; Vivanco J; Ruibal A
Seric BCM-RIA levels in patients with lung pathologies.
The International journal of biological markers 1991;6(1):37-8.
1990: Roiz M C; Vizoso F; Allende M T; Ruibal A
[The existence of a correlation between the serum values of MCA and CA 15.3 in patients with digestive tumors]
Revista clínica española 1990;187(7):376.
1990: Roiz C; Allende T; Fernández-García J; Vivanco J; Bianco A; Ruibal A
Correlation between breast cancer mucin (BCM) and CA 125 serum levels in patients with active ovarian tumors.
The International journal of biological markers 1990;5(4):207.
1990: Allende M T; Roiz M C; Vizoso F; Hernández J; Vivanco J; Ruibal A
Serum SLX levels in patients with non tumoral pathologies. Our experience in 189 cases.
The International journal of biological markers 1990;5(3):153-4.
1990: Vizoso F; Roiz M C; Allende M T; Ruibal A
[Correlation of serum concentrations of BCM and MCA, CA 549 and CA 15.3 in women with macrocystic disease of breast]
Medicina clínica 1990;94(8):319.
1990: Allende M T; Vizoso F; Fueyo A; Roiz M C; Lennartz L; Ruibal A
Serum BCM levels in patients with non-tumoral pathologies: a value of 25 U/ml can be used as threshold for tumoral activity.
The International journal of biological markers 1990;5(1):50-1.
1990: Allende M T; Vizoso F; Roiz M C; Fueyo A; Ruibal A
Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast disease.
The International journal of biological markers 1990;5(1):48-9.
1990: Soriano A; Allende M T; Vizoso F; Fernández García J; Vivanco J; Ruibal A
MCA and CA 15.3 serum levels in non-malignant diseases. Some preliminary results.
The International journal of biological markers 1990;5(1):46-7.
1989: Sagredo E; Soriano A; Pombo L; Roiz M C; Allende M T; Ruibal A
CA 72.4 serum levels in 298 patients with non-malignant diseases.
The International journal of biological markers 1989;4(2):125.
1989: Sagredo E; Soriano A; Vivanco F J; Ruibal A
[Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4]
Revista clínica española 1989;184(6):336-7.
1989: Ruibal A; Sagredo E; Soriano A; Roiz M C
[Serum TAG-72 in women with breast cancer: an example of serum/tissue discrepancy of a tumor marker]
Medicina clínica 1989;92(1):39.
1989: Sagredo E; Soriano A; Pombo L; Ruibal A
[Behavior of serum CA 72.4 in patients with non-tumor pathologies. Preliminary results]
Medicina clínica 1989;92(2):78-9.
1988: Soriano A; Pombo L; Sagredo E; Ruibal A
[Increase in serum mucin-like carcinoma-associated antigen (MCA) in patients with chronic liver diseases]
Medicina clínica 1988;91(17):675.
1988: Pombo L; Ruibal A; Soriano A; Duque J J; Fombellida J C
[Behavior of CEA MARIA (monoclonal antibody radioimmunoanalysis in the serum of patients with non-tumorous diseases. Comparison with polyclonal radioimmunoanalysis]
Revista clínica española 1988;183(7):383-4.
1988: Ruibal A; Pombo L; Soriano A; Lamiquiz A
[Quantitative increase of carcinoembryonic antigen (CEA) MARIA (monoclonal antibody radioimmunoassay) in relation to monoclonal CEA in colorectal cancer]
Medicina clínica 1988;90(18):756.

Sign-in to see more